It is important to mention that a non-negligible proportion of GEMMs in CRC research (e.g., Apc-mutated) develop tumors predominantly in the small intestine [19,31], which is in sharp contrast to the human situation [78]. This evidence concerns the gene APC and colorectal carcinoma.